Insights Into Drug Delivery Device Manufacturing From Development Through Commercialization

By Sheleagh Dougan and Meredith Canty, SMC Ltd.

Biologics and other targeted therapy techniques are creating opportunities for innovative device solutions that meet the needs of specific patient groups. As these therapies often require low annual volumes, the associated device manufacturing strategy must also fit commercial expectations, even at those volumes. Optimal manufacturing solutions should be identified to meet the quality, financial, timeline, and patient needs of the product. Download this paper for an overview of insights into drug delivery device manufacturing from development through commercialization.